overweight and obesity are major contributors to both type 2 diabetes and cardiovascular disease cvdmoreover individuals with type 2 diabetes who are overweight or obese are at particularly high risk for cvd morbidity and mortalityalthough shortterm weight loss has been shown to ameliorate obesityrelated metabolic abnormalities and cvd risk factors the longterm consequences of intentional weight loss in overweight or obese individuals with type 2 diabetes have not been adequately examinedthe primary objective of the look ahead clinical trial is to assess the longterm effects up to 115 years of an intensive weight loss program delivered over 4 years in overweight and obese individuals with type 2 diabetesapproximately 5000 male and female participants who have type 2 diabetes are 4574 years of age and have a body mass index or25 kgm2 will be randomized to one of the two groupsthe intensive lifestyle intervention is designed to achieve and maintain weight loss through decreased caloric intake and increased physical activitythis program is compared to a control condition given diabetes support and educationthe primary study outcome is time to incidence of a major cvd eventthe study is designed to provide a 090 probability of detecting an 18 difference in major cvd event rates between the two groupsother outcomes include components of cvd risk cost and costeffectiveness diabetes control and complications hospitalizations intervention processes and quality of life